Capecitabine-induced-coronary-vasospasm leading to polymorphic ventricular tachycardia and cardiac arrest
Abstract Capecitabine, a pro-drug of 5-fluorouracil, is commonly used in the treatment of breast and colorectal cancer. Its side effects, including nausea, vomiting, diarrhea, fatigue, loss of appetite, and bone marrow suppression, are well recognized. However, coronary vasospasm represents a less c...
Main Authors: | Maciej Kabat, Roma Padalkar, Sara Hazaveh, Vladimir Joseph, David Feigenblum, Sean Sadikot |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | Cardio-Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40959-024-00214-4 |
Similar Items
-
Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy
by: Uğur Nadir Karakulak, et al.
Published: (2016-02-01) -
Bidirectional Ventricular Tachycardia: A Hallmark of Catecholaminergic Polymorphic Ventricular Tachycardia
by: Dr. Francisco Femenia, MD, et al.
Published: (2012-03-01) -
Catecholaminergic polymorphic ventricular tachycardia: An exciting new era
by: Shashank P Behere, et al.
Published: (2016-01-01) -
Coronary artery vasospasm during catheter cryoablation of left ventricular summit nonsustained ventricular tachycardia
by: Santiago Rivera, MD, et al.
Published: (2016-11-01) -
Polymorphic ventricular tachycardia on a young patient
by: Osman Can Yontar
Published: (2014-07-01)